LKFT offering history
Every offering-related filing in Lakefront Biotherapeutics NV’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 528 filings back to Nov 14, 2007.
| Date | Filing | What it means | |
|---|---|---|---|
| May 8, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 29, 2019 | F-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Oct 15, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 14, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 13, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 18, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 17, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 1, 2016 | F-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| May 14, 2015 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 13, 2015 | F-1MEF → | REGISTERED | F-1MEF registration — capacity to sell shares, not a sale yet |
| May 13, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 12, 2015 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| May 12, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| May 11, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| May 7, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| May 5, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Apr 30, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Apr 30, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 15, 2015 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Mar 11, 2008 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
LKFT offering FAQ
When did LKFT last execute an offering?
Per SEC filings, Lakefront Biotherapeutics NV's most recent priced offering document is a 424B5 filed 2018-09-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did LKFT last announce or register an offering?
The most recent registration is a F-3ASR filed 2019-03-29. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.